Page 830 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

808 PART IV Specific Malignancies in the Small Animal Patient

447. Taylor S, Rozanski E, Sato AF, et al.: Vascular stent placement for 470. Jóźwiak S, Kotulska K, Kasprzyk-Obara J, et al.: Clinical and geno-
palliation of mass-associated chylothorax in two dogs, J Am Vet Med type studies of cardiac tumors in 154 patients with tuberous sclero-
Assoc 251:696–701, 2017. sis complex, Pediatrics 118:e1146–e1151, 2006.
VetBooks.ir 448. Wykes PM, Rouse GP, Orton EC: Removal of five canine cardiac 471. Sciacca P, Giacchi V, Mattia C, et al.: Rhabdomyomas and tuber-
ous sclerosis complex: our experience in 33 cases, BMC Cardiovasc
tumors using a stapling instrument, Vet Surg 15:103–106, 1986.
449. Ogilvie GK, Powers BE, Mallinckrodt CH, et al.: Surgery and
Disord 14, 66–66, 2014.
doxorubicin in dogs with hemangiosarcoma, J Vet Intern Med 472. Saad AM, Abushouk AI, Al-Husseini MJ, et al.: Characteristics,
10:379–384, 1996. survival and incidence rates and trends of primary cardiac malig-
450. Verbeke F, Binst D, Stegen L, et al.: Total venous inflow occlusion nancies in the United States, Cardiovasc Pathol 33:27–31, 2018.
and pericardial auto-graft reconstruction for right atrial hemangio- 473. Ramlawi B, Leja MJ, Abu Saleh WK, et al.: Surgical treatment of
sarcoma resection in a dog, Can Vet J 53:1114–1118, 2012. primary cardiac sarcomas: review of a single-institution experience,
451. Morges M, Worley DR, Withrow SJ, et al.: Pericardial free patch Ann Thorac Surg 101:698–702, 2016.
grafting as a rescue technique in surgical management of right atrial 474. Bakaeen FG, Reardon MJ, Coselli JS, et al.: Surgical outcome in
HSA, J Am Anim Hosp Assoc 47:224–228, 2011. 85 patients with primary cardiac tumors, Am J Surg 186:641–647,
452. Crumbaker DM, Rooney MB, Case JB: Thoracoscopic subtotal 2003.
pericardiectomy and right atrial mass resection in a dog, J Am Vet 475. Llombart-Cussac A, Pivot X, Contesso G, et al.: Adjuvant chemo-
Med Assoc 237:551–554, 2010. therapy for primary cardiac sarcomas: the IGR experience, Br J
453. Buchanan JW, Boggs LS, Dewan S, et al.: Left atrial paraganglioma Cancer 78:1624–1628, 1998.
in a dog: echocardiography, surgery, and scintigraphy, J Vet Intern 476. Abu Saleh WK, Ramlawi B, Shapira OM, et al.: Improved out-
Med 12:109–115, 1998. comes with the evolution of a neoadjuvant chemotherapy approach
454. Dunning D, Monnet E, Orton EC, et al.: Analysis of prognostic to right heart sarcoma, Ann Thorac Surg 104:90–96, 2017.
indicators for dogs with pericardial effusion: 46 cases (1985-1996), 477. Bussani R, De‐Giorgio F, Abbate A, et al.: Cardiac metastases,
J Am Vet Med Assoc 212:1276–1280, 1998. J Clin Pathol 60:27–34, 2007.
455. Case JB, Maxwell M, Aman A, et al.: Outcome evaluation of a 478. Moore PF: A review of histiocytic diseases in dogs and cats, Vet
thoracoscopic pericardial window procedure or subtotal pericardec- Pathol 51:167–184, 2014.
tomy via thoracotomy for the treatment of pericardial effusion in 479. Affolter VK, Moore PF: Canine cutaneous and systemic histiocyto-
dogs, J Am Vet Med Assoc 242:493–498, 2013. sis of dermal and dendritic origin, Am J Dermatopathol 22:40–48,
456. Atencia S, Doyle RS, Whitley NT: Thoracoscopic pericardial win- 2000.
dow for management of pericardial effusion in 15 dogs, J Small 480. Affolter VK, Moore PF: Localized and disseminated histiocytic sar-
Anim Pract 54:564–569, 2013. coma of dendritic cell origin in dogs, Vet Pathol 39:74–83, 2002.
457. Ployart S, Libermann S, Doran I, et al.: Thoracoscopic resection of 481. Moore PF, Affolter V, Olivry T, et al.: The use of immunological
right auricular masses in dogs: 9 cases (2003–2011), J Am Vet Med reagents in defining the pathogenesis of canine skin disease involv-
Assoc 242:237–241, 2012. ing proliferation of leukocytes. In Kwochka KW, Wilemse T, von
458. Mullin CM, Arkans MA, Sammarco CD, et al.: Doxorubicin che- Tscharner C, editors: Advances in veterinary dermatology, Oxford,
motherapy for presumptive cardiac hemangiosarcoma in dogs, Vet 1998, Butterworth-Heinemann, pp 77–94.
Comp Oncol 14:e171–e183, 2016. 482. Moore PF, Schrenzel MD, Affolter VK, et al.: Canine cutaneous
459. Ghaffari S, Pelio DC, Lange AJ, et al.: A retrospective evaluation of histiocytoma is an epidermotropic Langerhans cell histiocytosis
doxorubicin-based chemotherapy for dogs with right atrial masses that expresses CD1 and specific beta 2-integrin molecules, Am J
and pericardial effusion, J Small Anim Pract 55:254–257, 2014. Pathol 148:1699–1708, 1996.
460. Pellin MA, Wouda RM, Robinson K, et al.: Safety evaluation of 483. Moore PF, Affolter VK, Vernau W, et al.: Canine hemophagocytic
combination doxorubicin and toceranib phosphate (Palladia®) in histiocytic sarcoma: a proliferative disorder of CD11d+ macro-
tumour bearing dogs: a phase I dose‐finding study, Vet Comp Oncol phages, Vet Pathol 43:632–645, 2006.
15:919–931, 2016. 484. Shortman K, Naik SH: Steady-state and inflammatory dendritic-
461. de Madron E, Helfand SC, Stebbins KE: Use of chemotherapy for cell development, Nat Rev Immunol 7:19–30, 2007.
treatment of cardiac hemangiosarcoma in a dog, J Am Vet Med Assoc 485. Larregina at, Morelli AE, Spencer LA, et al.: Dermal-resident
190:887–891, 1987. CD14+ cells differentiate into Langerhans cells, Nat Immunol
462. Murphy LA, Panek CM, Bianco D, et al.: Use of Yunnan Baiyao 2:1151–1158, 2001.
and epsilon aminocaproic acid in dogs with right atrial masses and 486. Shortman K, Caux C: Dendritic cell development: multiple path-
pericardial effusion, J Vet Emerg Crit Care 27:121–126, 2017. ways to nature’s adjuvants, Stem Cells 15:409–419, 1997.
463. McQuown B, Arteaga T, Cunningham S, et al.: Palladia (toceranib 487. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes,
phosphate) in the treatment of heart base tumors, Vet Cancer Soc Nat Rev Immunol 2:151–161, 2002.
Ann Conf, 2014. 488. Ricklin ME, Roosje P, Summerfield A: Characterization of canine
464. Obradovich JE, Withrow SJ, Powers BE, et al.: Carotid body dendritic cells in healthy, atopic, and non-allergic inflamed skin,
tumors in the dog eleven cases (1978–1988), J Vet Intern Med J Clin Immunol 30:845–854, 2010.
6:96–101, 1992. 489. Zaba LC, Krueger JG, Lowes MA: Resident and “inflammatory”
465. Kelsey KL, Kubicek LN, Bacon NJ, et al.: Neuromuscular block- dendritic cells in human skin, J Invest Dermatol 129:302–308,
ade and inspiratory breath hold during stereotactic body radiation 2009.
therapy for treatment of heart base tumors in four dogs, J Am Vet 490. Looringh van Beeck FA, Zajonc DM, Moore PF, et al.: Two canine
Med Assoc 250:199–204, 2017. CD1a proteins are differentially expressed in skin, Immunogenetics
466. Reynen K: Frequency of primary tumors of the heart, Am J Cardiol 60:315–324, 2008.
77:107, 1996. 491. Danilenko DM, Moore PF, Rossitto PV: Canine leukocyte cell
467. Lam KY, Dickens P, Chan AC: Tumors of the heart. A 20-year adhesion molecules (LeuCAMS): characterization of the CD11/
experience with a review of 12,485 consecutive autopsies, Arch CD18 family, Tiss Antig 40:13–21, 1992.
Pathol Lab Med 117:1027–1031, 1993. 492. Danilenko DM, Rossitti PV, Van der Vieren M, et al.: A novel
468. McAllister HA, Hall RJ, Cooley DA: Tumors of the heart and peri- canine leukointegrin, alpha d beta 2, is expressed by specific
cardium, Curr Probl Cardiol 24:59–116, 1999. macrophage subpopulations in tissue and a minor CD8+ lym-
469. Shapiro LM: Cardiac tumours: diagnosis and management, Heart phocyte subpopulation in peripheral blood, J Immunol 155:35–
85:218–222, 2001. 44, 1995.